Thomas B Julian

Summary

Affiliation: Allegheny General Hospital
Country: USA

Publications

  1. ncbi Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer
    Thomas B Julian
    Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Am J Surg 184:315-7. 2002
  2. ncbi Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer
    Thomas B Julian
    Allegheny Breast Care Center, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA 15212, USA
    J Clin Oncol 26:3338-45. 2008
  3. ncbi Is sentinel node biopsy necessary in conservatively treated DCIS?
    Thomas B Julian
    National Surgical Adjuvant Breast and Bowel Project Operations Office and Biostatistical Center, Pittsburgh, Pennsylvania, USA
    Ann Surg Oncol 14:2202-8. 2007
  4. ncbi Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
    David N Krag
    National Surgical Adjuvant Breast and Bowel Project NSABP, Pittsburgh, PA, USA
    Lancet Oncol 11:927-33. 2010
  5. ncbi Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32
    Stephanie R Land
    National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center, University of Pittsburgh, Pittsburgh, PA 15213, USA
    J Clin Oncol 28:3929-36. 2010
  6. ncbi Reduction in radiation-induced morbidity by use of an intercurrent boost in the management of early-stage breast cancer
    Mark Trombetta
    Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Int J Radiat Oncol Biol Phys 77:1303-8. 2010
  7. ncbi The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project
    D Lawrence Wickerham
    NSABP Operations Office, Biostatistical Center and Graduate School of Public Health, University of Pittsburgh, and Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Semin Oncol 35:522-9. 2008
  8. ncbi Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ
    Hilary M Shapiro-Wright
    Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    J Natl Cancer Inst Monogr 2010:145-9. 2010
  9. ncbi The need for axillary dissection in patients with positive axillary sentinel lymph nodes
    Randal L Croshaw
    Department of Human Oncology, Drexel University College of Medicine, Philadelphia, PA, USA
    Curr Oncol Rep 13:5-10. 2011
  10. ncbi Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast
    Mark Trombetta
    Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Am J Clin Oncol 32:314-8. 2009

Detail Information

Publications34

  1. ncbi Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer
    Thomas B Julian
    Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Am J Surg 184:315-7. 2002
    ....
  2. ncbi Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer
    Thomas B Julian
    Allegheny Breast Care Center, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA 15212, USA
    J Clin Oncol 26:3338-45. 2008
    ..We present the results from a large, prospective evaluation of the first rapid molecular SLN test, the Breast Lymph Node (BLN) Assay...
  3. ncbi Is sentinel node biopsy necessary in conservatively treated DCIS?
    Thomas B Julian
    National Surgical Adjuvant Breast and Bowel Project Operations Office and Biostatistical Center, Pittsburgh, Pennsylvania, USA
    Ann Surg Oncol 14:2202-8. 2007
    ..Its use in patients with DCIS versus local excision (LE), observation, and/or breast irradiation remains in question...
  4. ncbi Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
    David N Krag
    National Surgical Adjuvant Breast and Bowel Project NSABP, Pittsburgh, PA, USA
    Lancet Oncol 11:927-33. 2010
    ....
  5. ncbi Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32
    Stephanie R Land
    National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center, University of Pittsburgh, Pittsburgh, PA 15213, USA
    J Clin Oncol 28:3929-36. 2010
    ..We report the definitive patient-reported outcomes (PRO) comparisons...
  6. ncbi Reduction in radiation-induced morbidity by use of an intercurrent boost in the management of early-stage breast cancer
    Mark Trombetta
    Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Int J Radiat Oncol Biol Phys 77:1303-8. 2010
    ..Herein, we compare patients treated with whole-breast irradiation followed by boost compared with a cohort with a planned intercurrent radiation boost...
  7. ncbi The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project
    D Lawrence Wickerham
    NSABP Operations Office, Biostatistical Center and Graduate School of Public Health, University of Pittsburgh, and Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Semin Oncol 35:522-9. 2008
    ....
  8. ncbi Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ
    Hilary M Shapiro-Wright
    Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    J Natl Cancer Inst Monogr 2010:145-9. 2010
    ..Routine use of sentinel node biopsy for DCIS is not supported...
  9. ncbi The need for axillary dissection in patients with positive axillary sentinel lymph nodes
    Randal L Croshaw
    Department of Human Oncology, Drexel University College of Medicine, Philadelphia, PA, USA
    Curr Oncol Rep 13:5-10. 2011
    ..The surgical approach to the treatment of breast cancer continues to move away from the traditional Halstedian concept...
  10. ncbi Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast
    Mark Trombetta
    Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Am J Clin Oncol 32:314-8. 2009
    ..To evaluate the cosmetic outcome of brachytherapy after lumpectomy in the management of carcinoma of the previously irradiated breast...
  11. ncbi Axillary recurrences following positive sentinel lymph node biopsy with individual tumor cells or micrometastases and no axillary dissection
    Kathleen M Erb
    Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Breast Dis 31:83-90. 2010
    ..One should consider the tumor characteristics, findings within the SLN, and a multidisciplinary treatment plan. Clinical trial results may help to resolve the dilemma. There appears to be a low risk for axillary recurrence...
  12. ncbi Completion of axillary dissection for a positive sentinel node: necessary or not?
    Kathleen M Erb
    Allegheny General Hospital, Pittsburgh, PA 15213, USA
    Curr Oncol Rep 11:15-20. 2009
    ..In selected patients, it may be appropriate to forgo an axillary node dissection, although there are no randomized clinical trial data to support or refute this suggestion...
  13. ncbi Mammary fat necrosis following radiotherapy in the conservative management of localized breast cancer: does it matter?
    Mark Trombetta
    Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Radiother Oncol 97:92-4. 2010
    ..We wish to assess the clinical significance of fat necrosis resulting from post-lumpectomy breast irradiation...
  14. ncbi The landmark surgical trials of the National Surgical Adjuvant Breast and Bowel Project
    D Lawrence Wickerham
    National Surgical Adjuvant Breast and Bowel Project NSABP, Pittsburgh, Pennsylvania 15212, USA
    World J Surg 30:1138-46. 2006
    ....
  15. ncbi Technical limitations of sentinel node biopsy in breast cancer: a single surgeon's experience
    Nilesh A Patel
    Department of Human Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA
    Am Surg 69:111-6. 2003
    ..In the present study SNB detection by both isotope and blue dye has been shown to be superior to blue dye alone. This finding demonstrates that these limitations may be overcome with the standardization of the technique used...
  16. ncbi Comparison of conservative management techniques in the re-treatment of ipsilateral breast tumor recurrence
    Mark Trombetta
    Department of Radiation Oncology, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, USA
    Brachytherapy 10:74-80. 2011
    ..To compare brachytherapy and three-dimensional (3-D) conformal external beam radiotherapy for breast cancer presenting in the previously irradiated breast...
  17. ncbi Correlation of the use of axillary ultrasound and lymph node needle biopsy with surgical lymph node pathology in patients with invasive breast cancer
    Michael S Cowher
    Department of Surgery, Allegheny General Hospital, Pittsburgh, PA, USA
    Am J Surg 196:756-9. 2008
    ..Results vary regarding the utility of perioperative axillary ultrasound (AUS) and biopsy for detecting axillary metastases...
  18. ncbi Neo-adjuvant hormonal therapy
    Marcia Valenzuela
    Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA
    Breast J 14:279-83. 2008
    ..Biomarker findings of improved response in tumors that are both estrogen receptor positive and HER-2 positive as well as progesterone receptor positivity only will be important for planning future selective treatment and clinical trials...
  19. ncbi Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches
    Stephanie R Land
    National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA 15213, USA
    J Clin Oncol 25:5113-20. 2007
    ..We describe the effectiveness of several interventions and of observational factors...
  20. ncbi Ductal carcinoma in situ: biology, diagnosis, and new therapies
    Marcia Valenzuela
    Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Clin Breast Cancer 7:676-81. 2007
    ..Genome-wide microarray-based gene expression analyses are now providing new opportunities to discover genes that are specifically activated or inactivated during the course of breast cancer progression...
  21. ncbi The allegheny general modification of the Harvard Breast Cosmesis Scale for the retreated breast
    Mark Trombetta
    Department of Radiation Oncology, Allegheny General Hospital, 320 East North Ave, Pittsburgh, PA 15212, USA
    Oncology (Williston Park) 23:954-6. 2009
    ..We propose a modification of the scale for patients who undergo retreatment--the Allegheny General Modification of the Harvard/NSABP/RTOG scoring scale...
  22. ncbi Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers
    Randal L Croshaw
    Allegheny General Hospital, 320 E North Avenue, Pittsburgh, PA 15212 4746, USA
    Int J Breast Cancer 2011:481563. 2011
    ..This paper reviews the available literature for breast conservation and surgical decision making in BRCA1/2 mutation carriers...
  23. ncbi Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer. An NSABP protocol B-32 quality assurance study
    Donald L Weaver
    Department of Pathology, College of Medicine, University of Vermont, Burlington, Vermont 05405 0068, USA
    Cancer 107:661-7. 2006
    ..2 mm but not larger than 2.0 mm) or isolated tumor cell clusters (< or = 0.2 mm). This study defines the rate at which pathologists miss metastases on CK IHC of sentinel lymph nodes (SLN)...
  24. ncbi Practice patterns of sentinel node biopsy at five comprehensive cancer centers
    David N Krag
    J Natl Cancer Inst 95:1498-9. 2003
  25. ncbi NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial
    David N Krag
    Department of Surgery, University of Vermont, Burlington, Vermont, USA
    Ann Surg Oncol 11:208S-10S. 2004
    ..A secondary aim of the B32 trial is to evaluate whether patients with "occult" metastases in the SNs have worse survival. Accrual is taking place at 73 institutions in North America, and 217 surgeons are enrolling patients...
  26. ncbi Accelerated partial breast irradiation after conservative surgery for breast cancer
    Henry M Kuerer
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Surg 239:338-51. 2004
    ..To critically review the theoretical and actual risks and benefits of accelerated partial breast irradiation (APBI) after breast-conserving surgery...
  27. ncbi Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative bre
    Seth P Harlow
    Department of Surgery, University of Vermont College of Medicine and the Vermont Cancer Center, Burlington 05405, USA
    Ann Surg 241:48-54. 2005
    ..To train surgeons in a standardized technique of sentinel lymph node biopsy and to prepare them for the requirements of a prospective randomized surgical trial...
  28. ncbi Mammographic density and breast cancer after ductal carcinoma in situ
    Laurel A Habel
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, CA 94612, USA
    J Natl Cancer Inst 96:1467-72. 2004
    ..Our results provide initial evidence that the risk of second breast cancers may be increased among DCIS patients with highly dense breasts...
  29. ncbi Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
    David N Krag
    University of Vermont, College of Medicine, Burlington, VT 05405 0068, USA
    Lancet Oncol 8:881-8. 2007
    ..The aim of this paper is to report the technical success and accuracy of SLN resection plus ALND versus SLN resection alone...
  30. ncbi Image-detected breast cancer: state of the art diagnosis and treatment
    Melvin J Silverstein
    USC-Norris Cancer Center, Los Angeles 90033, USA
    J Am Coll Surg 201:586-97. 2005
  31. ncbi Report of the Working Groups on Breast MRI: report of the Breast Cancer Staging Group
    Steven E Harms
    University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Breast J 10:S3-8. 2004
  32. ncbi Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial
    Constance D Lehman
    Department of Radiology, University of Washington, Seattle Cancer Care Alliance, Seattle, Washington 98109, USA
    J Surg Oncol 92:9-15; discussion 15-6. 2005
    ..To estimate the added cancer yield of magnetic resonance imaging (MRI) over mammography in the contralateral breast of patients with a recent diagnosis of breast cancer...
  33. ncbi MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer
    Constance D Lehman
    University of Washington Medical Center, Seattle, WA 98109, USA
    N Engl J Med 356:1295-303. 2007
    ....
  34. ncbi Report of the Working Groups on Breast MRI: report of the Biopsy and Intervention Working Group
    V Suzanne Klimberg
    University of Arkansas for Medical Sciences, Little Rock 72205-12191, USA
    Breast J 10:S13-6. 2004